Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

http://www.wikidata.org/entity/Q37234183

about

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma.CD44 family proteins in gastric cancer: a meta-analysis and narrative review Gastric cancer stem cells: evidence, potential markers, and clinical implications.The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.Ablation of osteopontin suppresses N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric cancer development in mice.CD44-SLC1A2 gene fusions in gastric cancer.Osteopontin at the Crossroads of Inflammation and Tumor Progression.

P2860

Q30244324-DDDE8AB5-0591-4AFC-AC44-65EF166EB37D Q34948623-6647301F-FFB3-43FE-909D-9E831C982D0A Q35577863-96F5F340-3422-4128-9376-76674988630A Q35643626-C9C05232-C29D-4BBD-B852-014D60BC27E8 Q35795934-D497FEB4-EB50-4716-A09C-090C05D1C9B1 Q35909530-F524F1F1-D92F-46E0-926C-A0BE2CB47EFB Q37688419-E6DB527D-8105-422A-9AE0-E6C49F9C56C1 Q38830146-0ED75409-35E8-4210-AC30-A8FB220151EB Q39563036-D6011792-C7C7-49DE-9F8F-EC27EB573E6B Q41099667-FDA3B4BD-6822-43CE-AEB4-36B13074C06B

P2860

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

http://www.wikidata.org/entity/Q37234183

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@en

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@nl

type

label

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@en

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@nl

prefLabel

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@en

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@nl

P1433

Q37234183-F72A59EF-9244-4A00-B807-5345D0405045

P1476

Q37234183-602CFFD6-C95E-430C-B642-E3862E32C5B7

P2093

Q37234183-1F2E7C88-BA13-4BF1-B925-179ABBC7C740

Q37234183-55C554AA-04A4-4CF4-83CD-B8EAA94E66F1

Q37234183-85011789-7587-4946-B554-C0FA997A68A3

Q37234183-A83F355C-C4F2-48F8-A572-9A8F63775F6F

Q37234183-BC1F67B2-3015-4A11-B376-33F9A8F4B218

P2860

Q37234183-0083002C-BC4B-4C07-A412-1D5FB2D941A4

Q37234183-0886673E-F8B4-4999-849A-97603C4E5752

Q37234183-0BC34F09-A7FA-4EAE-8670-4F9AD97F3C03

Q37234183-11E97FC3-111D-4E2F-B9E1-ACDB49A5AFD0

Q37234183-15AECE13-C2BC-47F8-AE7B-AB6F4E3960BD

Q37234183-26524AE8-ED2B-42D2-B2B4-C2B8F694ACDE

Q37234183-3802CA94-B082-4DA6-B871-51B2FE82A885

Q37234183-3C93D875-9CF7-4835-A2E2-E3296CF49468

Q37234183-46FBFE5F-BE22-4FB8-AC21-67DE362774CE

Q37234183-476E9155-463E-4528-9F1F-49D162F98312

P304

Q37234183-1FD5BAD2-9482-4262-B728-B77A1BF5566A

P31

Q37234183-78B9A104-2D6B-485E-8469-116ED5944BFD

P356

Q37234183-B67DB803-6685-4F91-95A7-75C2003CBFF4

P433

Q37234183-6A0F825E-4C29-45AF-A833-9DE70C6A2BD9

P478

Q37234183-395DA345-E2EB-4DD3-8034-A7B7F911F591

P577

Q37234183-F922F0CE-D769-48F4-882F-C7E9372F03E3

P5875

Q37234183-019B3BB4-B47D-4B0B-81D9-1EF4E69F2B3F

P698

Q37234183-521BFDFA-8736-408C-BD19-1AE210BBB157

P921

Q37234183-683A0391-CD93-4D13-BE87-E87AFA59CDD2

P932

Q37234183-2AC0DB85-08D9-4AA8-9690-842E6E470741

P356

CRT.2009.41.1.29

P1433

Cancer Research and Treatment

P1476

Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

@en

P2093

Byung-Noe Bae

http://www.w3.org/2001/XMLSchema#string

Eunah Shin

http://www.w3.org/2001/XMLSchema#string

Jung Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Kyeongmee Park

http://www.w3.org/2001/XMLSchema#string

Kyoung Soo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation

Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells

Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal

Molecular staging for survival prediction of colorectal cancer patients.

The metastasis gene osteopontin: a candidate target for cancer therapy.

The role of osteopontin in breast cancer: clinical and experimental studies.

CD44 is required for two consecutive steps in HGF/c-Met signaling.

Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.

P304

29-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2009.41.1.29

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26749099

http://www.w3.org/2001/XMLSchema#string

P698

19688069

http://www.w3.org/2001/XMLSchema#string

P921

P932

2699089

http://www.w3.org/2001/XMLSchema#string